Skip to main content

MetLife Investment Management, LLC

Position in PRME — Prime Medicine, Inc.

CIK 1529735 Whippany, NJ

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$207,348
+$53,505 QoQ
Shares Held
56,192
+27.1% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 187 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. PRME ranks #189 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $207,348 56,192
2026-03-31 $153,843 44,208
2025-12-31 $199,767 57,570
2025-09-30 $238,203 42,997
2025-06-30 $96,364 39,014
2024-12-31 $73,090 25,031
2024-09-30 $132,075 34,128
2024-06-30 $175,417 34,128
2024-03-31 $148,834 21,262
2023-12-31 $188,381 21,262
2023-09-30 $202,839 21,262
2023-06-30 $311,488 21,262
2023-03-31 $74,919 6,091
2022-12-31 $113,170 6,091